Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.73 |
| ▸ | USP2 | O75604 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.73 |
| ▸ | DHCR24 | Q15392 | 10/20 | 0.72 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12228032 | 1.00 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL1446268 | 1.00 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL28007790 | 1.00 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL29934505 | 1.00 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL15346215 | 1.00 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL3843445 | 1.00 | ALDH1A1 (0.73) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL23326519 | 0.94 | ALDH1A1 (0.66) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL599029 | 0.89 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL22318602 | 0.89 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL4434556 | 0.89 | ALDH1A1 (0.77) | ALDH1A1MEN1KMT2AUSP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007129133-A1 | OINTMENT OR CREAM FOR THE TOPICAL TREATMENT OF PSORIASIS | POLEO ROMERO ABEL (VE) | 2007-11-15 | — | — | WO | claimed |
| US-20260132353-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-05-14 | — | — | US | disclosed |
| US-12529007-B2 | Lipid comprising docosapentaenoic | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-01-20 | — | — | US | disclosed |
| US-12492354-B2 | Lipid comprising docosapentaenoic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2025-12-09 | — | — | US | disclosed |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | ALKALAY RACHEL (IL) | 2024-11-28 | — | — | US | disclosed |
| US-20240226218-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING A CORONAVIRUS INFECTION | Novel Concepts Medical Ltd (IL) | 2024-07-11 | — | — | US | disclosed |
| US-20240084214-A1 | LIPID COMPRISING POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2024-03-14 | — | — | US | disclosed |
| US-11834621-B2 | Lipid comprising polyunsaturated fatty acids | Nuseed Global Innovation Ltd. (GB) | 2023-12-05 | — | — | US | disclosed |
| US-20230348357-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-11-02 | — | — | US | disclosed |
| US-20230346866-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NON-MALIGNANT RESPIRATORY DISEASE | Novel Concepts Medical Ltd (IL) | 2023-11-02 | — | — | US | disclosed |
| EP-3266316-A1 | PRODUCTION OF LONG CHAIN POLYUNSATURATED FATTY ACIDS IN PLANT CELLS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2018-01-10 | — | — | EP | disclosed |
| EP-2861059-B1 | PRODUCTION OF LONG CHAIN POLYUNSATURATED FATTY ACIDS IN PLANT CELLS | COMMW SCIENT IND RES ORG (AU) | 2017-05-03 | — | — | EP | disclosed |
| US-20130288318-A1 | HIGH OLEIC ACID OILS | GRAINS RESEARCH AND DEVELOPMENT CORPORATION (AU) | 2013-10-31 | — | — | US | disclosed |
| EP-1268511-B1 | PROCESS FOR PRODUCING DIELS-ALDER ADDUCTS OF STEROL 5,7-DIENES USING UNSATURATED FATTY ACID CATALYST | DSM IP ASSETS BV (NL) | 2008-05-28 | — | — | EP | disclosed |
| CN-1315510-C | Antiviral composition derived from allium cepa and therapeutic use thereof | DIEPON S A (UY) | 2007-05-16 | — | — | CN | disclosed |
| CN-1622755-A | antiviral composition from onion and therapeutic use thereof | DIEPON S A (UY) | 2005-06-01 | — | — | CN | disclosed |
| EP-1268511-A1 | PROCESS FOR PRODUCING DIELS-ALDER ADDUCTS OF STEROL 5,7-DIENES USING UNSATURATED FATTY ACID CATALYST | Roche Vitamins AG (CH) | 2003-01-02 | — | — | EP | disclosed |
| US-6399796-B2 | ISOLATION FROM A STEROL MIXTURE BY EXOGENOUSLY PROVIDING A CATALYTIC AMOUNT OF AN UNSATURATED C12-C24 CARBOXYLIC FATTY ACID TO THE REACTION OF THE STEROLDIENE AND A DIENOPHILE | ROCHE VITAMINS INC. | 2002-06-04 | — | — | US | disclosed |
| US-20010047093-A1 | Activation of a diels-alder reaction of a sterol 5,7 diene | MONSANTO TECHNOLOGY LLC (US) | 2001-11-29 | — | — | US | disclosed |
| WO-2001070760-A1 | PROCESS FOR PRODUCING DIELS-ALDER ADDUCTS OF STEROL 5,7-DIENES USING UNSATURATED FATTY ACID CATALYST | ROCHE VITAMINS AG (CH) | 2001-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529007-B2 | Lipid comprising docosapentaenoic | DAGLA, SCD, FADS2 | ALDH1A1 3413/4885MEN1 4385/4885KMT2A 3831/4885 |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | TPO, TNF, ADAMTS13 | ALDH1A1 2644/4885MEN1 287/4885KMT2A 3939/4885 |
| US-20260132353-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | ELOVL3, SCD, ELOVL6 | ALDH1A1 3801/4885MEN1 3350/4885KMT2A 3268/4885 |
| US-20010047093-A1 | Activation of a diels-alder reaction of a sterol 5,7 diene | DHCR7, SCD5, CYP11A1 | ALDH1A1 499/4885MEN1 2069/4885KMT2A 4729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.